ArticleClinical case reports2025
Atypical Manifestation of Primary Antiphospholipid Syndrome: Conservative Management of Celiac Trunk Thrombosis Case Report and Literature Review.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aortic and celiac trunk thrombosis is an exceptional manifestation of antiphospholipid syndrome (APS). A 36-year-old woman with triple-positive APS, prior ischemic strokes, and chronic hypertension discontinued her anticoagulation therapy with acenocoumarin 1 week before presenting sudden, severe, transfixing epigastric and mesogastric pain radiating to the back, nausea, vomiting, and hypertension (174/118 mmHg). Initial tests showed anemia (9.8 g/dL), leukocytosis, elevated LDH, and an INR of 1.44. The abdominal CT angiography revealed an aortic stenosis of 54% caused by a thrombus extending into the celiac trunk (95% stenosis) and subacute splenic infarction. Anticoagulation was resumed alongside analgesia. One week later, celiac stenosis reduced to 44%. She was discharged on enoxaparin, hydroxychloroquine, and nifedipine. After 1 month, blood pressure was controlled, and a small residual aortic thrombus persisted without celiac trunk thrombosis evidence. This case highlights the importance of early recognition of APS and its complications, including rare vascular manifestations, and illustrates the potential role of conservative treatment in managing the rare vascular manifestation of APS, where standardized treatment guidelines are lacking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.